Sato A - Search Results

1

[First/second/third-line chemotherapy with molecular targeted drugs for colorectal cancer].

Sato A, Nakamachi M, Imataka H. Sato A, et al. Gan To Kagaku Ryoho. 2009 Aug;36(8):1242-6. Gan To Kagaku Ryoho. 2009. PMID: 19692761 Japanese.

2

[Chemotherapy of gastric cancer--a review of clinical trials in Japan].

Sato A, Ito T, Tomita T, Nakamura A, Taguchi S. Sato A, et al. Gan To Kagaku Ryoho. 2002 Sep;29(9):1522-31. Gan To Kagaku Ryoho. 2002. PMID: 12355938 Review. Japanese.

3

Effectiveness of doxifluridine (5'-DFUR)/docetaxel against advanced/recurrent gastric cancer showing resistance to various anticancer drug regimens.

Sato A, Shimada K, Nakamachi M, Ushio J, Yamamoto W, Kurihara M, Matsukawa M. Sato A, et al. Gastric Cancer. 2002;5(4):233-6. doi: 10.1007/s101200200040. Gastric Cancer. 2002. PMID: 12491082

4

[Hypersensitivity reactions to cancer chemotherapeutic agents].

Sato A, Sakashita A, Taguchi S. Sato A, et al. Gan To Kagaku Ryoho. 2003 Jun;30(6):793-800. Gan To Kagaku Ryoho. 2003. PMID: 12852346 Review. Japanese.

5

[Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module].

Morita S, Shimozuma K, Sato A, Nakamachi M, Blazeby J, West K, Fukuhara S, Sakamoto J. Morita S, et al. Among authors: sato a. Gan To Kagaku Ryoho. 2004 Aug;31(8):1195-9. Gan To Kagaku Ryoho. 2004. PMID: 15332542 Japanese.

6

[A feasibility study of oxaliplatin (L-OHP) in combination with infusional 5-FU/l-LV (FOLFOX4 regimen) for advanced colorectal cancer].

Suenaga M, Nishina T, Hyodo I, Munakata M, Koizumi W, Mishima H, Sato A, Mizunuma N, Hatake K. Suenaga M, et al. Among authors: sato a. Gan To Kagaku Ryoho. 2008 Feb;35(2):255-60. Gan To Kagaku Ryoho. 2008. PMID: 18281761 Clinical Trial. Japanese.

7

[Clinical development of chemotherapy for advanced gastric cancer].

Sato A, Nakamachi M. Sato A, et al. Gan To Kagaku Ryoho. 2008 Sep;35(9):1461-6. Gan To Kagaku Ryoho. 2008. PMID: 18799898 Japanese.

8

[Gastric cancer].

Sato A, Nakamachi M. Sato A, et al. Gan To Kagaku Ryoho. 2009 Feb;36(2):176-81. Gan To Kagaku Ryoho. 2009. PMID: 19223732 Japanese.

9

Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer.

Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Sato A, Koizumi W, Mizunuma N, Takiuchi H. Doi T, et al. Among authors: sato a. Jpn J Clin Oncol. 2010 Oct;40(10):913-20. doi: 10.1093/jjco/hyq069. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462981 Free PMC article. Clinical Trial.

10

[Clinical development of oral chemotherapeutic agents for advanced gastric cancer].

Sato A, Nakamachi M, Imataka H, Hamada K. Sato A, et al. Gan To Kagaku Ryoho. 2010 Jul;37(7):1192-7. Gan To Kagaku Ryoho. 2010. PMID: 20647697 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,479 results

Search Page

Filters